United States· US:10967-633_2a968ae6-b455-db91-e063-6294a90a4022
Revlon Mitchum Clinical Gel
A medicinal product containing aluminum zirconium octachlorohydrex gly, registered in United States by Revlon Consumer Products Corp.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY
- Manufacturer
- Revlon Consumer Products Corp
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc11109676330259 mL in 1 CONTAINER (10967-633-02)
- ndc11109676336017 mL in 1 CONTAINER (10967-633-60)
- ndc1110967-633-02
- ndc1110967-633-60
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cdd330a0-57b1-4634-a102-33984edd17cb GET /v1/drugs/cdd330a0-57b1-4634-a102-33984edd17cb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": ".2",
"substance": "ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY",
"productndc": "10967-633",
"dosage_form": "LIQUID",
"dea_schedule": null,
"strength_unit": "g/mL",
"application_number": "M019",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about aluminum zirconium octachlorohydrex gly.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.